Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale CEO sold 2,804 shares at $15.81 ($44,331)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 8-K Event Executive or director change
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Open-market sale EVP, Chief Financial Officer sold 653 shares at $17.91 ($11,695)
  9. 8-K Event Executive or director change · Shareholder vote results
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 34,208 shares (grant or award)
  16. S-3ASR Offering Registration Statement
  17. DEFR14A Other DEFR14A
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. CT ORDER Other Confidential Order

Page 15 of 70 · 1,382 filings